Structural and mechanistic insight into N-glycan processing by endo-α-mannosidase
Author(s) -
Andrew J. Thompson,
R.J. Williams,
Z. Hakki,
Dominic S. Alonzi,
Tom Wennekes,
T.M. Gloster,
Kriangsak Songsrirote,
Jane ThomasOates,
Tanja M. Wrodnigg,
Josef Spreitz,
Arnold Stütz,
Terry D. Butters,
Spencer J. Williams,
G.J. Davies
Publication year - 2012
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.1111482109
Subject(s) - mannosidase , glycan , chemistry , glycoside hydrolase , enzyme , biochemistry , cleavage (geology) , endoplasmic reticulum , stereochemistry , anomer , iminosugar , endoplasmic reticulum associated protein degradation , biology , glycoprotein , paleontology , cytosol , fracture (geology)
N-linked glycans play key roles in protein folding, stability, and function. Biosynthetic modification of N-linked glycans, within the endoplasmic reticulum, features sequential trimming and readornment steps. One unusual enzyme, endo-α-mannosidase, cleaves mannoside linkages internally within an N-linked glycan chain, short circuiting the classical N-glycan biosynthetic pathway. Here, using two bacterial orthologs, we present the first structural and mechanistic dissection of endo-α-mannosidase. Structures solved at resolutions 1.7-2.1 Å reveal a (β/α)(8) barrel fold in which the catalytic center is present in a long substrate-binding groove, consistent with cleavage within the N-glycan chain. Enzymatic cleavage of authentic Glc(1/3)Man(9)GlcNAc(2) yields Glc(1/3)-Man. Using the bespoke substrate α-Glc-1,3-α-Man fluoride, the enzyme was shown to act with retention of anomeric configuration. Complexes with the established endo-α-mannosidase inhibitor α-Glc-1,3-deoxymannonojirimycin and a newly developed inhibitor, α-Glc-1,3-isofagomine, and with the reducing-end product α-1,2-mannobiose structurally define the -2 to +2 subsites of the enzyme. These structural and mechanistic data provide a foundation upon which to develop new enzyme inhibitors targeting the hijacking of N-glycan synthesis in viral disease and cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom